Canopy Growth CGC
NASDAQ CGC
$1.05 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Canopy Growth (CGC) Cash from Financing Activities (2019 - 2026)

Canopy Growth (CGC) posted Cash from Financing Activities of $204.9 million for Q4 2025, up 1015.35% sequentially from $18.4 million in Q2 2025, and up 1051.17% YoY from $17.8 million in Q4 2024.

Canopy Growth (CGC) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Canopy Growth has reported Cash from Financing Activities for 7 years, with the latest figure at $204.9 million in Q4 2025.

  • Quarterly Cash from Financing Activities rose 1051.17% year-over-year to $204.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $267.0 million (up 109.76% YoY) and the FY2026 annual result came in at $242.4 million, up 133.96% from the prior year.
  • Cash from Financing Activities rose to $204.9 million in Q4 2025 per CGC's latest filing, from $18.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $786.6 million in Q1 2021 and troughed at -$204.5 million in Q3 2023.
  • A 5-year average of $40.7 million and a median of -$273368.7 in 2021 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 36245.01% in 2022, then jumped 14591.67% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $272114.3 in 2021, then tumbled by 36245.01% to -$98.4 million in 2022, then jumped by 50.54% to -$48.6 million in 2023, then surged by 55.71% to -$21.5 million in 2024, then surged by 1051.17% to $204.9 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $204.9 million, $18.4 million, and -$21.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -1.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -813.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -1.13 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 122.40 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -1.24 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 63.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -74.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Canopy Growth 449.71 Mn 202.70 Mn 16.08 Mn -5.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.40 Mn
Jun 30, 2026 -5.40 Mn
Dec 31, 2025 204.94 Mn
Dec 31, 2025 204.94 Mn
Jun 30, 2025 18.37 Mn
Jun 30, 2025 18.37 Mn
Dec 31, 2024 -21.55 Mn
Dec 31, 2024 -21.55 Mn
Sep 30, 2024 65.20 Mn
Sep 30, 2024 65.20 Mn
Jun 30, 2024 77.34 Mn
Jun 30, 2024 77.34 Mn
Mar 31, 2024 6.28 Mn
Mar 31, 2024 6.28 Mn
Dec 31, 2023 -48.65 Mn
Dec 31, 2023 -48.65 Mn
Sep 30, 2023 -204.53 Mn
Sep 30, 2023 -204.53 Mn
Jun 30, 2023 -99.09 Mn
Jun 30, 2023 -99.09 Mn